301, E Square
Subhash Road Vile Parle (East)
91 22 4084 2222
Industry: Drug Manufacturers—General
Full Time Employees:
|Mr. Rahul Jayant Nachane||CEO, MD, Chief Ethics Counsellor & Exec. Director||26.69M||N/A||1964|
|Mr. Rajesh Narayan Lawande||Whole Time Director & CFO||26.55M||N/A||1976|
|Mr. Ahaan Nachane||VP||N/A||N/A||N/A|
|Ms. Pallavi Pednekar||Company Sec. & Compliance Officer||N/A||N/A||N/A|
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, and marbofloxacin for animal health applications; and nitazoxanide, atovaquone, and ranolazine for human health applications. The company also provides various intermediate products; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
NGL Fine-Chem Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.